Literature DB >> 15118108

PIKE-A is amplified in human cancers and prevents apoptosis by up-regulating Akt.

Jee-Yin Ahn1, Yuanxin Hu, Todd G Kroll, Paulette Allard, Keqiang Ye.   

Abstract

PIKE-A (PIKE-activating Akt), an isoform of PIKE GTPase that enhances phosphatidylinositol 3-kinase (PI3-kinase) activity, specifically binds to active Akt but not PI3-kinase. PIKE-A stimulates Akt activity in a GTP-dependent manner and promotes invasiveness of cancer cell lines. Here, we show that PIKE-A is amplified in a variety of human cancers and that amplified PIKE-A directly stimulates Akt and inhibits apoptosis compared to cells with normal PIKE-A copy number. Overexpression of PIKE-A wild-type but not dominant-negative mutant stimulates Akt activity and prevents apoptosis. Moreover, knockdown of PIKE-A diminishes Akt activity and increases apoptosis. Our findings suggest that PIKE-A amplification contributes to cancer cell survival and progression by inhibiting apoptosis through up-regulating Akt.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15118108      PMCID: PMC406454          DOI: 10.1073/pnas.0400921101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells.

Authors:  D Maier; G Jones; X Li; A H Schönthal; O Gratzl; E G Van Meir; A Merlo
Journal:  Cancer Res       Date:  1999-11-01       Impact factor: 12.701

2.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

3.  How BAD phosphorylation is good for survival.

Authors:  J Downward
Journal:  Nat Cell Biol       Date:  1999-06       Impact factor: 28.824

4.  Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

Authors:  S R Datta; H Dudek; X Tao; S Masters; H Fu; Y Gotoh; M E Greenberg
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

5.  Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells.

Authors:  K Ye; Y Ke; N Keshava; J Shanks; J A Kapp; R R Tekmal; J Petros; H C Joshi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

6.  Pike. A nuclear gtpase that enhances PI3kinase activity and is regulated by protein 4.1N.

Authors:  K Ye; K J Hurt; F Y Wu; M Fang; H R Luo; J J Hong; S Blackshaw; C D Ferris; S H Snyder
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

7.  Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt.

Authors:  L del Peso; M González-García; C Page; R Herrera; G Nuñez
Journal:  Science       Date:  1997-10-24       Impact factor: 47.728

8.  CREB is a regulatory target for the protein kinase Akt/PKB.

Authors:  K Du; M Montminy
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

9.  Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

Authors:  V Stambolic; A Suzuki; J L de la Pompa; G M Brothers; C Mirtsos; T Sasaki; J Ruland; J M Penninger; D P Siderovski; T W Mak
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

10.  Regulation of cell death protease caspase-9 by phosphorylation.

Authors:  M H Cardone; N Roy; H R Stennicke; G S Salvesen; T F Franke; E Stanbridge; S Frisch; J C Reed
Journal:  Science       Date:  1998-11-13       Impact factor: 47.728

View more
  41 in total

1.  Phosphoinositide 3-kinase enhancer regulates neuronal dendritogenesis and survival in neocortex.

Authors:  Chi Bun Chan; Xia Liu; Sompol Pradoldej; Chunhai Hao; Jie An; Manuel Yepes; Hongbo R Luo; Keqiang Ye
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

Review 2.  Molecular heterogeneity of glioblastoma and its clinical relevance.

Authors:  Katalin Eder; Bernadette Kalman
Journal:  Pathol Oncol Res       Date:  2014-08-27       Impact factor: 3.201

3.  What we have learnt about PIKE from the knockout mice.

Authors:  Chi Bun Chan; Keqiang Ye
Journal:  Int J Biochem Mol Biol       Date:  2011-06-07

4.  Tumor Necrosis Factor-α Promotes Phosphoinositide 3-Kinase Enhancer A and AMP-Activated Protein Kinase Interaction to Suppress Lipid Oxidation in Skeletal Muscle.

Authors:  Margaret Chui Ling Tse; Oana Herlea-Pana; Daniel Brobst; Xiuying Yang; John Wood; Xiang Hu; Zhixue Liu; Chi Wai Lee; Aung Moe Zaw; Billy K C Chow; Keqiang Ye; Chi Bun Chan
Journal:  Diabetes       Date:  2017-04-12       Impact factor: 9.461

Review 5.  Contribution of AZAP-Type Arf GAPs to cancer cell migration and invasion.

Authors:  Vi Luan Ha; Ruibai Luo; Zhongzhen Nie; Paul A Randazzo
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

6.  Fyn-phosphorylated PIKE-A binds and inhibits AMPK signaling, blocking its tumor suppressive activity.

Authors:  S Zhang; Q Qi; C B Chan; W Zhou; J Chen; H R Luo; C Appin; D J Brat; K Ye
Journal:  Cell Death Differ       Date:  2015-05-22       Impact factor: 15.828

7.  Fyn regulates adipogenesis by promoting PIKE-A/STAT5a interaction.

Authors:  Margaret Chui Ling Tse; Xia Liu; Seran Yang; Keqiang Ye; Chi Bun Chan
Journal:  Mol Cell Biol       Date:  2013-02-25       Impact factor: 4.272

8.  GGAP2/PIKE-a directly activates both the Akt and nuclear factor-kappaB pathways and promotes prostate cancer progression.

Authors:  Yi Cai; Jianghua Wang; Rile Li; Gustavo Ayala; Michael Ittmann; Mingyao Liu
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

9.  Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship.

Authors:  Hyunsoo Kim; Wei Huang; Xiuli Jiang; Brenton Pennicooke; Peter J Park; Mark D Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-13       Impact factor: 11.205

10.  Deficiency of phosphoinositide 3-kinase enhancer protects mice from diet-induced obesity and insulin resistance.

Authors:  Chi Bun Chan; Xia Liu; Dae Young Jung; John Y Jun; Hongbo R Luo; Jason K Kim; Keqiang Ye
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.